"10.1371_journal.ppat.1004010","plos pathogens","2014-03-20T00:00:00Z","Mary F Kearney; Jonathan Spindler; Wei Shao; Sloane Yu; Elizabeth M Anderson; Angeline O'Shea; Catherine Rehm; Carry Poethke; Nicholas Kovacs; John W Mellors; John M Coffin; Frank Maldarelli","HIV-1 Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America; Advanced Biomedical Computing Center, SAIC, Frederick, Maryland, United States of America; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH Bethesda, Maryland, United States of America; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America; Department of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, United States of America","Conceived and designed the experiments: MFK JWM JMC FM. Performed the experiments: MFK JS SY. Analyzed the data: WS EMA NK. Contributed reagents/materials/analysis tools: MFK FM AOS CR CP. Wrote the paper: MFK JWM JMC FM.","John Mellors is a consultant for Gilead Sciences and owns share options in RFS Pharmaceuticals. This does not alter our adherence to all PLoS Pathogens policies on sharing data and materials.","2014","03","Mary F Kearney","MFK",12,TRUE,4,3,3,4,TRUE,FALSE,FALSE,0,NA,FALSE
